scholarly journals Protein Kinase C δ Induces Transcription of the TP53 Tumor Suppressor Gene by Controlling Death-Promoting Factor Btf in the Apoptotic Response to DNA Damage

2007 ◽  
Vol 27 (24) ◽  
pp. 8480-8491 ◽  
Author(s):  
Hanshao Liu ◽  
Zheng-Guang Lu ◽  
Yoshio Miki ◽  
Kiyotsugu Yoshida
Keyword(s):  
Dna Damage ◽  
Protein Kinase C ◽  
Protein Kinase ◽  
Tumor Suppressor ◽  
Gene Transcription ◽  
Core Promoter ◽  
Genotoxic Stress ◽  
Tp53 Gene ◽  
Transcriptional Level ◽  
Kinase C

ABSTRACT Expression of the TP53 tumor suppressor is tightly controlled for its ability to function as a critical regulator of cell growth, proliferation, and death in response to DNA damage. However, little is known about the mechanisms and contributions of the transcriptional regulation of TP53. Here we report that protein kinase C δ (PKCδ), a ubiquitously expressed member of the novel subfamily of PKC isoforms, transactivates TP53 expression at the transcriptional level. Reporter assays demonstrated that PKCδ induces the promoter activity of TP53 through the TP53 core promoter element (CPE-TP53) and that such induction is enhanced in response to DNA damage. The results also demonstrate that, upon exposure to genotoxic stress, PKCδ activates and interacts with the death-promoting transcription factor Btf to co-occupy CPE-TP53. Inhibition of PKCδ activity decreases the affinity of Btf for CPE-TP53, thereby reducing TP53 expression at both the mRNA and the protein levels. In concert with these results, we show that disruption of Btf-mediated TP53 gene transcription by RNA interference leads to suppression of TP53-mediated apoptosis following genotoxic stress. These findings provide evidence that activation of TP53 gene transcription by PKCδ triggers TP53-dependent apoptosis in response to DNA damage.

scholarly journals Protein Kinase C δ Activates Topoisomerase IIα To Induce Apoptotic Cell Death in Response to DNA Damage

2006 ◽  
Vol 26 (9) ◽  
pp. 3414-3431 ◽  
Author(s):  
Kiyotsugu Yoshida ◽  
Tomoko Yamaguchi ◽  
Hirokuni Shinagawa ◽  
Naoe Taira ◽  
Keiichi I. Nakayama ◽  
...  
Keyword(s):  
Dna Damage ◽  
Protein Kinase C ◽  
Protein Kinase ◽  
Cell Fate ◽  
Topoisomerase Ii ◽  
Apoptotic Cell ◽  
Genotoxic Stress ◽  
Topoisomerase Iiα ◽  
Kinase C ◽  
Topological State

ABSTRACT DNA topoisomerase II is an essential nuclear enzyme that modulates DNA processes by altering the topological state of double-stranded DNA. This enzyme is required for chromosome condensation and segregation; however, the regulatory mechanism of its activation is largely unknown. Here we demonstrate that topoisomerase IIα is activated in response to genotoxic stress. Concomitant with the activation, the expression of topoisomerase IIα is increased following DNA damage. The results also demonstrate that the proapoptotic kinase protein kinase C δ (PKCδ) interacts with topoisomerase IIα. This association is in an S-phase-specific manner and is required for stabilization and catalytic activation of topoisomerase IIα in response to DNA damage. Conversely, inhibition of PKCδ activity attenuates DNA damage-induced activation of topoisomerase IIα. Finally, aberrant activation of topoisomerase IIα by PKCδ is associated with induction of apoptosis upon exposure to genotoxic agents. These findings indicate that PKCδ regulates topoisomerase IIα and thereby cell fate in the genotoxic stress response.

Endotoxin-Induced Tissue Factor in Human Monocytes is Dependent upon Protein Kinase C Activation

1993 ◽  
Vol 70 (05) ◽  
pp. 800-806 ◽  
Author(s):  
C Ternisien ◽  
M Ramani ◽  
V Ollivier ◽  
F Khechai ◽  
T Vu ◽  
...  
Keyword(s):  
Protein Kinase C ◽  
Protein Kinase ◽  
Tissue Factor ◽  
Factor Ix ◽  
Transcriptional Level ◽  
Mrna Levels ◽  
Dependent Manner ◽  
Human Monocytes ◽  
Kinase C ◽  
Pkc Activation

SummaryTissue factor (TF) is a transmembrane receptor which, in association with factors VII and Vila, activates factor IX and X, thereby activating the coagulation protease cascades. In response to bacterial lipopolysaccharide (LPS) monocytes transcribe, synthesize and express TF on their surface. We investigated whether LPS-induced TF in human monocytes is mediated by protein kinase C (PKC) activation. The PKC agonists phorbol 12- myristate 13-acetate (PMA) and phorbol 12, 13 dibutyrate (PdBu) were both potent inducers of TF in human monocytes, whereas 4 alpha-12, 13 didecanoate (4 a-Pdd) had no such effect. Both LPS- and PMA-induced TF activity were inhibited, in a concentration dependent manner, by three different PKC inhibitors: H7, staurosporine and calphostin C. TF antigen determination confirmed that LPS-induced cell-surface TF protein levels decreased in parallel to TF functional activity under staurosporine treatment. Moreover, Northern blot analysis of total RNA from LPS- or PMA-stimulated monocytes showed a concentration-dependent decrease in TF mRNA levels in response to H7 and staurosporine. The decay rate of LPS-induced TF mRNA evaluated after the arrest of transcription by actinomycin D was not affected by the addition of staurosporine, suggesting that its inhibitory effect occurred at a transcriptional level. We conclude that LPS-induced production of TF and its mRNA by human monocytes are dependent on PKC activation.

scholarly journals p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization

1999 ◽  
Vol 337 (3) ◽  
pp. 607-616 ◽  
Author(s):  
Makoto AKASHI ◽  
Yoshiaki OSAWA ◽  
H. Phillip KOEFFLER ◽  
Misao HACHIYA
Keyword(s):  
Protein Kinase C ◽  
Protein Kinase ◽  
Phorbol Esters ◽  
P53 Protein ◽  
Mitogen Activated Protein Kinase ◽  
Luciferase Reporter ◽  
Transcriptional Level ◽  
Kinase C ◽  
In Cells

p21WAF1 inhibits cyclin–cyclin-dependent kinase (Cdk) complexes, causing cell cycle arrest. p21WAF1 contains p53-binding sites in its promoter and expression of p21WAF1 is induced by functional p53. In the present work, we have studied the role of protein kinase C (PKC) in the induction of p21WAF1 and show that induction of p21WAF1 expression can occur by activation of PKC in cells having no p53. Human ovarian carcinoma cells, SKOV-3, lack p53 protein and PMA, a potent activator of PKC, did not induce p53. PMA increased the expression of p21WAF1 mRNA both in these cells and in other cells which do not contain p53 (THP-1 and U937). Treatment of human embryonic fibroblasts, WI38, with PMA also induced the accumulation of p21WAF1 without affecting p53 levels. However, PMA did not increase levels of p21WAF1 mRNA in cells where either the PKC or the mitogen-activated protein kinase pathway was blocked. Furthermore, treatment of cells with various phorbol ester derivatives which activate PKC resulted in the induction of p21WAF1 in SKOV-3 cells. In contrast, phorbol esters which do not activate PKC failed to induce p21WAF1 expression. PMA increased the transcriptional rate of p21WAF1 and activated the transcription of a luciferase reporter gene, controlled by the p21 promoter, in SKOV-3 cells with or without a p53 consensus-binding sequence. By contrast, PMA markedly stabilized p21WAF1 mRNA; the half-life (t1/2) of p21WAF1 in PMA-treated cells was > 8 h compared with < 1 h in untreated cells. These findings provide evidence that the PKC pathway induces expression of p21WAF1 independently of p53. Our present study also suggests that the accumulation of p21WAF1 transcripts by PMA occurs mainly at post-transcriptional level.

Abstract 125: Protein kinase C loss-of-function mutations in cancer reveal role as tumor suppressor

2015 ◽  
Author(s):  
Corina E. Antal ◽  
Andrew M. Hudson ◽  
Emily Kang ◽  
Ciro Zanca ◽  
Christopher Wirth ◽  
...  
Keyword(s):  
Protein Kinase C ◽  
Protein Kinase ◽  
Tumor Suppressor ◽  
Loss Of Function ◽  
Kinase C
Sign in / Sign up

Export Citation Format

Share Document